Researchers at Texas A&M, in partnership with the University of Minnesota, have received a three point eight million dollar grant to develop drugs for treating m-pox, formerly known as monkeypox.
According to the university news release, the college of veterinary medicine will work to develop antiviral drugs for treating the disease that creates a noticeable rash and blisters.
M-pox made headlines in May of 2022 when a global outbreak spread to all 50 states in the United States.